TTY Biopharm Company Limited (TPEX: 4105)

TTY Biopharm Company Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 9, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	18,201	19,991	20,737	17,107	17,057	20,489
Market Cap Growth	-2.93%	-3.60%	21.22%	0.29%	-16.75%	7.71%
Enterprise Value	18,467	20,061	20,686	16,707	17,498	20,328
Last Close Price	73.20	76.95	76.41	60.43	57.22	65.31
PE Ratio	16.23	16.99	17.37	18.09	15.42	18.09
PS Ratio	3.18	3.63	4.10	3.77	4.04	4.59
PB Ratio	3.13	3.07	3.33	2.97	2.81	3.32
P/FCF Ratio	18.27	19.85	18.12	14.30	47.61	17.97
P/OCF Ratio	17.41	18.42	16.78	13.62	32.41	16.93
EV/Sales Ratio	3.23	3.64	4.09	3.68	4.14	4.55
EV/EBITDA Ratio	10.79	12.81	14.69	12.82	15.75	14.76
EV/EBIT Ratio	12.06	14.62	16.85	14.65	18.28	16.55
EV/FCF Ratio	18.53	19.92	18.08	13.97	48.84	17.83
Debt / Equity Ratio	0.37	0.29	0.29	0.37	0.35	0.31
Debt / EBITDA Ratio	1.54	1.19	1.28	1.65	1.93	1.40
Debt / FCF Ratio	2.42	1.85	1.58	1.79	5.98	1.70
Asset Turnover	0.58	0.57	0.54	0.49	0.45	0.48
Inventory Turnover	2.15	2.08	2.05	1.71	1.64	1.94
Quick Ratio	1.41	1.62	1.35	1.23	1.42	1.33
Current Ratio	1.85	2.08	1.73	1.56	1.88	1.64
Return on Equity (ROE)	18.29%	17.56%	18.38%	13.89%	15.98%	14.45%
Return on Assets (ROA)	8.71%	8.81%	8.12%	7.64%	6.33%	8.25%
Return on Capital (ROIC)	10.05%	10.46%	9.62%	8.84%	7.33%	9.60%
Earnings Yield	6.16%	5.64%	5.28%	4.86%	5.42%	4.39%
FCF Yield	5.47%	5.04%	5.52%	6.99%	2.10%	5.56%
Dividend Yield	4.76%	4.55%	4.45%	4.96%	6.99%	6.12%
Payout Ratio	77.45%	74.91%	68.16%	119.56%	107.62%	124.31%
Buyback Yield / Dilution	-0.04%	-0.03%	0.02%	0.00%	-0.03%	0.01%
Total Shareholder Return	4.72%	4.52%	4.47%	4.97%	6.96%	6.13%

Source: S&P Capital IQ. Standard template. Financial Sources.